151 related articles for article (PubMed ID: 2910700)
1. [Retard morphine in the long-term therapy of severe tumor pain].
Zenz M; Strumpf M; Tryba M; Röhrs E; Steffmann B
Dtsch Med Wochenschr; 1989 Jan; 114(2):43-7. PubMed ID: 2910700
[TBL] [Abstract][Full Text] [Related]
2. [Long-term therapy of tumor pain using morphine-retard tablets].
Sorge J; Lehmkuhl C; Lohse K; Herrmann H; Pichlmayr I
Med Klin (Munich); 1990 Sep; 85(9):523-8. PubMed ID: 2233610
[TBL] [Abstract][Full Text] [Related]
3. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of chronic pain in advanced malignant disease by oral morphine (author's transl)].
Brulé G; Belnat P; Apchin A; Domenge C; Voisin PM
Nouv Presse Med; 1979 Oct; 8(39):3119-21. PubMed ID: 537869
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
6. [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].
Schulzeck S; Gleim M; Maier C
Anaesthesist; 1993 Aug; 42(8):545-56. PubMed ID: 8368476
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tolerance in long-term treatment of cancer pain with epidural morphine.
Caputi CA; Busca G; Fogliardi F; Giugliano F
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):587-90. PubMed ID: 6654534
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.
Sen S; Aydin ON; Aydin K
Pain Med; 2006; 7(2):166-9. PubMed ID: 16634730
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
12. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
Arkinstall WW; Goughnour BR; White JA; Stewart JH
CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
[TBL] [Abstract][Full Text] [Related]
13. Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain.
Panich A; Charnvej L
J Med Assoc Thai; 1993 Dec; 76(12):672-6. PubMed ID: 7798818
[TBL] [Abstract][Full Text] [Related]
14. The use of sustained-release morphine in a hospice setting.
Sherman LM
Pharmatherapeutica; 1987; 5(2):99-102. PubMed ID: 3659062
[TBL] [Abstract][Full Text] [Related]
15. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
16. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
19. [Long-term treatment with intrathecal morphine in severe painful cancer].
Eriksen K; Bigler D; Jensen NH; Eriksen J
Ugeskr Laeger; 1989 Sep; 151(37):2365-6. PubMed ID: 2477927
[TBL] [Abstract][Full Text] [Related]
20. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
